Summary
Boston Scientific Corporation (BSX) filed an 8-K on February 2, 2012, to report its financial results for the fourth quarter and full year ended December 31, 2011. The core of this filing is the press release attached as Exhibit 99.1, which contains the company's operational and financial performance for the period. Investors should refer to this press release for detailed information on revenue, profitability, and other key financial metrics. The filing itself primarily serves as a notification mechanism, directing stakeholders to the publicly issued press release for the substance of the results. While the 8-K filing itself does not contain the detailed financial figures, it confirms the official release of these results. Investors are therefore advised to access Exhibit 99.1, the press release dated February 2, 2012, for a comprehensive understanding of Boston Scientific's financial condition and results of operations for the specified periods. This includes any forward-looking statements or management commentary included within that press release.
Key Highlights
- 1Boston Scientific Corporation (BSX) announced its fourth quarter and full year 2011 financial results.
- 2The official financial results were disclosed via a press release on February 2, 2012.
- 3This 8-K filing's primary purpose is to furnish the press release containing the financial results.
- 4Investors are directed to Exhibit 99.1 (the press release) for detailed financial performance information.
- 5The information is furnished, not filed, under Section 18 of the Exchange Act, limiting liability for this specific disclosure.
- 6The filing does not contain the actual financial statements or detailed operational data, but points to the accompanying press release.